| Abstrakt: |
A study conducted by researchers at Masaryk University in the Czech Republic analyzed the outcomes of pregnancy in women treated with different antihypertensive drugs. The study used nationwide data on births and abortions from 2012 to 2022 and classified women as having pre-existing hypertension or pregnancy-induced hypertension. The researchers found that the risk of maternal and fetal complications was higher with calcium channel blockers, such as amlodipine, compared to methyldopa and beta-blockers. Bisoprolol, verapamil, and diuretics were found to have a risk of adverse outcomes comparable to methyldopa, while amlodipine and multiple antihypertensive drug combinations were associated with an increased risk. [Extracted from the article] |
